Skip to main content
. 2015 Apr 15;88(2):164–167. doi: 10.15386/cjmed-459

Figure 3.

Figure 3

Changes of IL-10 levels in plasma of TB patients (n=18) before anti-tuberculous therapy (ATT0), after three months (ATT3) and at the end of treatment (ATT6), * p<0.05.